（Years ended/ending March 31, million yen）
|
2026 1Q |
2027 1Q |
YoY (%) |
YoY excl. Abbott products (%) |
|
|
Domestic Sales |
30,686 |
26,080 |
-15.0 |
0.3 |
|
Overseas Sales (Overseas Sales Ratio) |
19,334 （38.7%） |
21,325 （45.0%） |
10.3 |
ー |
|
North America |
11,015 |
11,684 |
6.1 |
ー |
|
Latin America |
1,026 |
968 |
-5.6 |
ー |
|
Europe |
2,919 |
3,857 |
32.1 |
ー |
|
Asia & Other |
3,473 |
4,814 |
10.1 |
ー |
*Abbott products will be discontinued in Japan at the end of December 2026.
2027 1Q (3 months) ended June 30, 2026
Japan: Nihon Kohden concentrated on enhancing sales activities which match each market; the acute care hospital market, the small and mid-sized hospital market, and the clinic market. Sales of in-house products increased as the Company focused on strengthening its marketing and service capabilities, creating customer value which contributed to improving medical safety, patient outcomes, and operating efficiency. However, domestic sales decreased due to lower sales of Abbott products and restraining sales of locally purchased products. On a comparable basis excluding the impact of the discontinuation of Abbott products, domestic sales remained flat. Sales in the university, public hospital, and private hospital markets remained flat, while sales in the clinic market decreased.
International: Sales achieved double-digit growth on a yen basis and low-single-digit growth on a local currency basis. In North America, sales increased on a yen basis and decreased on a local currency basis. Sales of ventilators continued to increase significantly, and sales of AEDs, patient monitors, and neurology products decreased on a local currency basis. Sales in Latin America decreased, mainly in Guatemala and Paraguay, where sales had shown strong growth in FY2025 1Q, while sales in Mexico increased significantly. Sales in Europe increased significantly, thanks to large orders in Greece and Poland, as well as strong growth in the Netherlands and Germany. Sales in Asia & Other achieved double-digit growth, mainly in the Middle East & Africa and India.
